Made from type I and type III collagen, Geistlich Pharma North America’s Fibro-Gide collagen matrix is smart-linked, which the company calls a unique form of cross-linking that provides elasticity, strength, and volume stability.
Positioned as an alternative connective tissue graft, Fibro-Gide is designed for soft-tissue augmentation around natural teeth and implants. It also is indicated for alveolar ridge reconstruction for prosthetic treatment and recession defects for root coverage.
In contrast to connective tissue grafts that are considered to be the gold standard in soft-tissue augmentation and recession coverage procedures, Fibro-Gide does not require a second surgical site, the company says. It also is ready to use and has an unlimited supply.
“Unlike connective tissue grafts, where you are limited by the patient’s anatomy, Geistlich Fibro-Gide offers variable thickness, allowing the clinician the opportunity to choose the desired and optimal thickness for the procedure,” said Dr. Alan Fener of Jacksonville, Fla.
Designing a preferred alternative to the soft-tissue graft involved years of development and more than a thousand prototypes, said the company, adding that Fibro-Gide demonstrates safety and efficacy and shows clinical comparability to a connective tissue graft.
Related Articles
Penn Dental Investigates Taurolidine for Periodontitis Treatment
Alloderm Reverse Tunneling: A Novel Approach for Treating Gingival Recession
Scaffold Uses Growth Factor to Improve Periodontal Regeneration
